Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
110.41
-0.62 (-0.56%)
At close: Jul 1, 2026, 4:00 PM EDT
112.23
+1.82 (1.65%)
After-hours: Jul 1, 2026, 5:54 PM EDT
Rhythm Pharmaceuticals Market Cap
Rhythm Pharmaceuticals has a market cap or net worth of $7.57 billion as of July 1, 2026. Its market cap has increased by 90.63% in one year.
Market Cap
7.57B
Enterprise Value
7.34B
1-Year Change
90.63%
Ranking
Category
Stock Price
$110.41
Market Cap Chart
Since October 5, 2017, Rhythm Pharmaceuticals's market cap has increased from $813.90M to $7.57B, an increase of 829.68%. That is a compound annual growth rate of 29.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 7.57B | 5.93% |
| Dec 31, 2025 | 7.14B | 107.63% |
| Dec 31, 2024 | 3.44B | 26.64% |
| Dec 29, 2023 | 2.72B | 65.56% |
| Dec 30, 2022 | 1.64B | 227.07% |
| Dec 31, 2021 | 501.70M | -61.82% |
| Dec 31, 2020 | 1.31B | 30.30% |
| Dec 31, 2019 | 1.01B | 9.04% |
| Dec 31, 2018 | 925.00M | 16.66% |
| Dec 29, 2017 | 792.90M | -2.58% |
| Oct 5, 2017 | 813.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxcyte | 8.33B |
| Immunovant | 7.91B |
| TG Therapeutics | 7.90B |
| Spyre Therapeutics | 7.83B |
| Protagonist Therapeutics | 7.82B |
| ABIVAX Société Anonyme | 7.58B |
| Mirum Pharmaceuticals | 7.50B |
| PTC Therapeutics | 6.77B |